Taiwan ’s Ministry of Health and Welfare (Ministry of Health and Welfare) issued an amendment to the “Measures for the Implementation or Use of Specific Medical Technical Inspection and Inspection Medical Devices” on September 4, 2018 (referred to as the special tube method), opening up 6 cell therapy technologies, including those from In vivo immune cell therapy for cancer patients and end-stage patients with solid cancer who have failed standard treatment; autologous chondrocyte transplantation for knee joint cartilage defects; autologous fat stem cell transplantation for large area burns and difficult wound healing ...
One year so far, the medical institutions that have applied for approval currently have two hospitals: Taipei General Hospital and Taichung Chinese Medical University Hospital. They can perform autoimmune cells to treat malignant hematological tumors and some stage 4 solid cancers. In addition, there are currently more than 50 applications from 26 medical institutions under review, which will be announced on the website of the Ministry of Health and Welfare.(https://is.gd/lRvZ4T )。
According to the Ministry of Health and Welfare, the current clinical evidence indicates that cell therapy is not a panacea for cancer treatment. You should seek professional advice from your physician. Do not listen to exaggerated and illegal advertisements in the letter and call on the public to report to the local health bureau if found To avoid the victimization of innocent people.
At present, the cell therapy market can be described as a contention, not only anti-cancer immune cells but also anti-aging stem cells ... and other related items are really wide and deep. Patients or demanders must go online to find information to do their homework In order to understand the second one, it can be said that it is very difficult. It is even more difficult to find patients or friends with relevant experience. They are willing to provide valuable experience for everyone to share and share, as another objective reference and judgment. In view of this, this platform is specially constructed as a communication channel between doctors and patients.
The sponsor of the conference (platform) is Mr. Huang Xiaowen, who has served for two terms as the chairman of the Republic of China Enterprise Management Association and the vice chairman of the Danish English Education Foundation of the Consortium ... Now he is the chief consultant of Hengding Group and several students. Based on the original intention of giving back to the society, we have established and promoted this public welfare exchange platform, with a view to contributing to the society.
Invite Mr. Zhan Jingyao, Ms. Huang Youyi, Mr. Lu Guanru, etc. to form an executive team to invest in the initial planning and construction. First serve the public with an Internet platform, and formally establish a substantive exchange in the future depending on the timing and needs.
I am looking forward to sharing the experience with people from all walks of life who agree with the purpose of this association.